{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:25:40Z","timestamp":1783693540475,"version":"3.55.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T00:00:00Z","timestamp":1548288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13256-018-1916-4","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T20:02:48Z","timestamp":1548273768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fluocinolone acetonide intravitreal implant as a therapeutic option for severe Sj\u00f6gren\u2019s syndrome-related keratopathy: a case report"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7025-8280","authenticated-orcid":false,"given":"Joanna","family":"Wasielica-Poslednik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Gericke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,24]]},"reference":[{"issue":"2","key":"1916_CR1","first-page":"379","volume":"28","author":"FB Vivino","year":"2001","unstructured":"Vivino FB, Minerva P, Huang CH, Orlin SE. Corneal melt as the initial presentation of primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 2001;28(2):379\u201382.","journal-title":"J Rheumatol"},{"issue":"1","key":"1916_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","volume":"44","author":"C Selmi","year":"2018","unstructured":"Selmi C, Generali E, Gershwin ME. Rheumatic manifestations in autoimmune liver disease. Rheum Dis Clin North Am. 2018;44(1):65\u201387. \n                    https:\/\/doi.org\/10.1016\/j.rdc.2017.09.008\n                    \n                  .","journal-title":"Rheum Dis Clin North Am"},{"issue":"14","key":"1916_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12950-017-0174-3","volume":"21","author":"KC Shih","year":"2017","unstructured":"Shih KC, Lun CN, Jhanji V, Thong BY, Tong L. Systematic review of randomized controlled trials in the treatment of dry eye disease in Sjogren syndrome. J Inflamm (Lond). 2017;21(14):26. \n                    https:\/\/doi.org\/10.1186\/s12950-017-0174-3\n                    \n                  .","journal-title":"J Inflamm (Lond)"},{"issue":"8","key":"1916_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00393-007-0231-z","volume":"66","author":"E Feist","year":"2007","unstructured":"Feist E, D\u00f6rner T, Hansen A. Indications and options of new immune modulatory therapies for Sj\u00f6gren\u2019s syndrome [in German]. Z Rheumatol. 2007;66(8):679\u201385.","journal-title":"Z Rheumatol."},{"issue":"3","key":"1916_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ophtha.2012.09.014","volume":"120","author":"PA Campochiaro","year":"2013","unstructured":"Campochiaro PA, Nguyen QD, Hafiz G, Bloom S, Brown DM, Busquets M, Ciulla T, Feiner L, Sabates N, Billman K, Kapik B, Green K, Kane FE, FAMOUS Study Group. Aqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implants. Ophthalmology. 2013;120(3):583\u20137. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2012.09.014\n                    \n                  .","journal-title":"Ophthalmology"},{"issue":"6","key":"1916_CR6","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clinre.2017.07.002","volume":"41","author":"T Liwinski","year":"2017","unstructured":"Liwinski T, Schramm C. Autoimmune hepatitis - update on clinical management in 2017. Clin Res Hepatol Gastroenterol. 2017;41(6):617\u201325. \n                    https:\/\/doi.org\/10.1016\/j.clinre.2017.07.002\n                    \n                  .","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"10","key":"1916_CR7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/S0161-6420(02)01176-4","volume":"109","author":"O Weijtens","year":"2002","unstructured":"Weijtens O, Schoemaker RC, Romijn FP, Cohen AF, Lentjes EG, van Meurs JC. Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate. Ophthalmology. 2002;109(10):1887\u201391.","journal-title":"Ophthalmology"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1916-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-018-1916-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-018-1916-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T19:13:04Z","timestamp":1579806784000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-018-1916-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,24]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1916"],"URL":"https:\/\/doi.org\/10.1186\/s13256-018-1916-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,24]]},"assertion":[{"value":"25 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was not required for this case report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"21"}}